News Releases
-
Nov 14, 2011
BioTime Cell Information now available in GeneCards®The new GeneCards release identifies BioTime's ACTCellerate™ human embryonic progenitor (hEP) cell lines that express specific gene expression markers and links users directly to BioTime's commercial database.
Read More
-
Nov 14, 2011
GeneCards® Version 3.07 ReleasedXennex Inc. announced today the release of GeneCards®, Version 3.07, available at www.genecards.org.
Read More
-
Mar 2, 2010
GeneCards® Version 3.0 ReleasedXennex Inc. announced today the release of GeneCards®, Version 3.0, available at www.genecards.org. V3 features significantly upgraded infrastructure, including a comprehensive relational biological database, and a novel, sophisticated and speedier search engine.
Read More
-
May 13, 2009
GeneCards® Version 3.0 Beta ReleasedXennex Inc. announced today a major leap for GeneCards®, with the release of Version 3.0 beta
Read More
-
Apr 20, 2009
Xennex Inc. Providing Satoris Inc. with Latest GeneCards® ToolsXennex Inc. Providing Satoris Inc. with Latest GeneCards® Tools for Characterization of Protein Biomarkers Associated With Neurological Conditions
Read More
-
Sep 22, 2008
GeneCards® Links to Tocris Research ReagentsThe world leading online database of genes directly links to Tocris
Read More
-
May 5, 2008
Japan Patent Office Licenses GeneCards® from Xennex, Inc.Japan Patent Office Licenses GeneCards® from Xennex, Inc. Xennex, Inc. Partners with Bioscene in Japan - Expands Presence in Japan
Read More
-
Nov 15, 2007
The GeneCards family proudly announces A Decade of GeneCards®Join us for an International Symposium Celebrating A Decade of GeneCards® at the Weizmann Institute of Science
Read More
-
Sep 25, 2005
Israeli-US initiative provides one-stop shop for gene explorationA US-Israeli start-up is now offering pharmaceutical and biotechnology companies an innovative data mining tool that can help speed up the process of gene research enabling them to bring new life saving drugs and treatments to market quicker.
Read More
-
May 12, 2005
Improving the IP SearchThe issues of what constitutes a new, patentable invention and what is protected by an issued patent are continuously being redefined and tested in the marketplace and in the courts. Effective resources to draft, prosecute, and examine patent applications, such as sophisticated data sources, will benefit all sides involved in the biotech patents arena.
Read More
-
Jul 5, 2005
Applied Biosystems' TaqMan® Genomic Assays to Be Included in GeneCards®Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, and Xennex, Inc., the exclusive provider of commercial licenses for the GeneCards® database of human genes, today announced an agreement whereby Applied Biosystems TaqMan(R) Genomic Assays will be accessible via GeneCards. Under the terms of agreement, Applied Biosystems will provide GeneCards customers direct access to its entire collection of nearly three million genomic assays.
Read More
-
Mar 28, 2005
European Patent Office Licenses GeneCards® from Xennex, Inc.Xennex Inc. announced today that the European Patent Office (EPO) has licensed its GeneCards® product. GeneCards® will be utilized to assist in the review and approval of patent applications in the life sciences area.
Read More
-
Feb 9, 2005
LION bioscience and Xennex Announce PartnershipLION bioscience and Xennex Inc. today announced that they will deliver an integrated solution to the Life Science Market. Under the agreement, the two companies will develop wrappers for the human genes´ compendium GeneCards®, enabling LION’s SRS users to view GeneCards® data within SRS.
Read More